Episode 17 - Conclusion: Treatment Advancements and Final Remarks

During this segment, Patricia K. Coyle, MD, Leslie Fish, PharmD, and Gary M. Owens, MD, explain how research has expanded in the neurology field and discuss the therapeutic pipeline for multiple sclerosis (MS) with Dr Fred Lublin.

Dr Coyle discusses the potential of newly developing agents and explains that clinical trials are now testing the efficacy of these products, which is vital when considering data for future clinical guidelines.

However, Dr Owens suggests that expensive costs of treatment and the lack of clinical recommendations or guidelines can cause confusion to clinicians and challenge the future of MS.

Related Videos
Screenshot of Sancy Leachman, MD, PhD, smiling
Sam Holliday, Oshi Health
Dr. Milena Pavlova
Dr. Shruti Agnihotri
Screenshot of Sancy Leachman, MD, PhD
Nicolas Ferreyros, BA, managing director, Community Oncology Alliance
Sashi Naidu, MD, Carolina Blood and Cancer Care Associates
Dr. Lalan Wilfong
Related Content
© 2023 MJH Life Sciences
All rights reserved.